202 life-threatening bleeding cases linked to synthetic marijuana; 5 dead

The CDC issued a public warning of internal bleeding linked to synthetic marijuana containing rat poison after reporting 202 cases, including five deaths, according to a guidance the agency published May 25.

Advertisement

Nine state health departments reported the 202 cases and five deaths, since health officials began tracking the outbreak in March.

The majority of cases (164) were reported from Illinois. Maryland reported 20 cases, and Florida, Indiana, Kentucky, Missouri, Pennsylvania, Virginia and Wisconsin reported six or fewer cases per state.

Testing revealed the synthetic marijuana was laced with brodifacoum, a pesticide that causes severe bleeding.

The CDC recommends people avoid synthetic cannabinoids. The agency also issued a guidance that helps physicians identify and report cases and cautions high-risk patients, such those sent home from surgeries that may lead to bleeding.

To view the full guidance, click here.

More articles on clinical leadership and infection control: 
Researchers are working on tech to monitor handwashing in hospitals 24/7
Men get better acute stroke care than women in UK hospital study
Healthcare has a waste problem. Here’s what hospitals can do about it.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.